 |
Trisaccharides A and B |
|---|---|
| Trade Name | Biosynject |
| Orphan Indication | Moderate to severe clinical forms of hemolytic disease of the newborn arising from placental transfer of antibodies against blood group substances A and B |
| USA Market Approval | USA |
| USA Designation Date | 1987-04-12 00:00:00 |
| Sponsor | Chembiomed, Ltd.;P.O. Box 8050, T6H 4NP; |
